Fusion Antibodies plc carries a market capitalization of 14.39M, placing it among publicly traded companies globally.
| Market Cap | 14.39M |
| Enterprise Value | N/A |
Fusion Antibodies plc's stock has gained approximately 82.53968% over the past 52 weeks. The 50-day moving average sits at 12.84, while the 200-day moving average is 13.68.
| Beta (5Y) | N/A |
| 52-Week Price Change | 82.53968% |
| 50-Day Moving Average | 12.84 |
| 200-Day Moving Average | 13.68 |
| Average Volume (20 Days) | N/A |